Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 88 results for "sarabjit kour nangra"

Tech Mahindra and many small caps have indicated trend of lowe...

In an interview with ET Now, Sarabjit Kour Nangra from Angel Broking expresses her outlook on lower revenue trends indicated by Tech Mahindra and other IT organizations. ET Now: Tech Mahindra has come out with its report, they are saying that the ... Economic Times, 2 days ago
TechM projects tepid Q1 revenues, stock dives 7% The Financial Chronicle, 2 days ago

1 images for "sarabjit kour nangra"

Business Standard, 5 months ago
DNA

See no dramatic impact of H1-B probe on TCS, Infosys: Angel

T Below is the transcript of Sarabjit Kour Nangra's & Ajay Bagga's interview with Latha Venkatesh & Ekta Batra on CNBC-TV18. Latha: Did you get to read the New York Times article and the flashes that we ran, is this going to be a major negative ...
 Moneycontrol.com2 weeks ago Most of large-cap pharma stocks are pretty balanced in terms of valuation: Sarabjit Kour Nangra, Angel Broking  Economic Times1 month ago Ranbaxy effect playing on Sun Pharma's margins: Pros  Money Control1 month ago HCL Tech shares tank nearly 10% as Q3 earnings disappoint  DNA2 months ago

Infosys guidance a sure sign that they mean business: Sarabjit Kour Nangra, Angel Broking

They have been guiding again and again that FY17 onwards, they expect Infosys to be back being the bellwether company in terms of the IT sector. In an interview with ET Now, Sarabjit Kour Nangra, VP - Research, Angel Broking, shares her views on the Infosys ...
 Economic Times2 months ago

Dr Reddy's initiates recall of two drugs in US

A year after the last recall of its generic hypertension drug Metroprolol, Hyderabad-based Dr Reddy's Laboratories Limited has initiated a nationwide voluntary recall of two more drugs earlier this month -Divalproex Sodium extended release tablets ...
 Business Standard India2 days ago

Gujarat pharma companies focus on OTC herbal products

AHMEDABAD: Leading drug makers from the state are turning to plant extracts. Gujarat based companies, primarily engaged into manufacturing of drugs, are now focusing on over-the-counter (OTC) herbal products. Pankaj Patel promoted Zydus Cadila, ...
 Times of India5 days ago

Lupin readies Rs7,500 cr chest for buyouts [DNA : Daily News & Analysis (India)]

Mumbai: Drugmaker Lupin on Tuesday said its Board of directors has given an in-principle approval for raising up to Rs 7,500 crore. The company is looking at some big-ticket acquisitions and may utilise the funds for the purpose, industry experts ...
 Pharmacy Choice6 days ago Lupin readies Rs 7,500 crore war chest  DNA India1 week ago Lupin to raise Rs 7,500 cr, sets off acquisition buzz on D-St.  Financial Chronicle1 week ago

AstraZeneca rallies over 37% in June on Forxiga launch; more gains likely

MUMBAI: Shares of AstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41 per cent since June 3. It surged 9.5 per cent intraday today and given the buying momentum, it can ...
 Economic Times1 week ago
Money Today

Aurobindo Pharma gets USFDA approval for Azithromycin, shares up

BT Online Bureau New Delhi Last Updated: June 22, 2015 | 00:00 IST Aurobindo Pharma shares were trading higher on the bourses on Monday after it announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and ...
 Money Today1 week ago
News India Times

Infosys, TCS under US scrutiny over visas for IT workers

Washington/Bengaluru, June 12 The US has opened an investigation into two top Indian IT companies -- Tata Consultancy Services and Infosys -- for possible violations of rules for H-1B visas for foreign technology workers, according to a media ...
 ProKerala.com2 weeks ago
[x]  

US begins probe into alleged visa violation by TCS, Infosys

Bengaluru, June 12 The US government is learnt to have begun investigating alleged H1-B visa violations by Indian software majors Tata Consultancy Services (TCS) and Infosys Ltd, according to a US media report. The US labor department has ...
 ProKerala.com2 weeks ago Angel Broking maintains 'Buy' on Infosys, TCS  MyIris2 weeks ago 'US begins probe into alleged visa violation by TCS, Infosys'  Daijiworldcom2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sarabjit kour nangra
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less